Novanta Inc. (LON:0VAG)
London · Delayed Price · Currency is GBP · Price in USD 143.98
-1.92 (-1.32%)
At close: Feb 12, 2026
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Automation Enabling Technologies Revenue | 497.95M | 490.62M | 499.22M | |||||||||||
Automation Enabling Technologies Revenue Growth | 1.49% | -1.72% | -6.53% | |||||||||||
Medical Solutions Revenue (Post-Q3 2024 Reporting) | 462.36M | 458.63M | 382.44M | |||||||||||
Medical Solutions Revenue (Post-Q3 2024 Reporting) Growth | 0.81% | 19.92% | 17.02% | |||||||||||
Revenue (Total) | 960.31M | 949.25M | 881.66M | |||||||||||
Revenue (Total) Growth | 1.17% | 7.66% | 2.41% |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Precision Medicine and Manufacturing Revenue | - | - | 282.97M | |||||||||||
Precision Medicine and Manufacturing Revenue Growth | - | - | 3.02% | |||||||||||
Medical Solutions Revenue (Pre-Q4 2024 Reporting) | - | - | 325.22M | |||||||||||
Medical Solutions Revenue (Pre-Q4 2024 Reporting) Growth | - | - | 16.99% | |||||||||||
Robotics and Automation Revenue | 314.23M | 288.32M | 273.47M | |||||||||||
Robotics and Automation Revenue Growth | 8.99% | 5.43% | -11.28% | |||||||||||
Revenue (Total) | 960.31M | 949.25M | 881.66M | |||||||||||
Revenue (Total) Growth | 1.17% | 7.66% | 2.41% |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
United States Revenue | 504.50M | 487.11M | 418.27M | |||||||||||
United States Revenue Growth | 3.57% | 16.46% | 12.33% | |||||||||||
Germany Revenue | 107.42M | 123.24M | 128.23M | |||||||||||
Germany Revenue Growth | -12.84% | -3.89% | -4.11% | |||||||||||
Rest of Europe Revenue | 138.08M | 128.87M | 137.03M | |||||||||||
Rest of Europe Revenue Growth | 7.14% | -5.95% | -0.56% | |||||||||||
China Revenue | 91.36M | 84.56M | 73.44M | |||||||||||
China Revenue Growth | 8.04% | 15.14% | -24.42% | |||||||||||
Rest of Asia-Pacific Revenue | 99.80M | 107.05M | 105.35M | |||||||||||
Rest of Asia-Pacific Revenue Growth | -6.78% | 1.62% | 3.69% | |||||||||||
Other Geographic Revenue | 19.16M | 18.40M | 19.35M | |||||||||||
Other Geographic Revenue Growth | 4.15% | -4.90% | 5.99% | |||||||||||
Revenue (Total) | 960.31M | 949.25M | 881.66M | |||||||||||
Revenue (Total) Growth | 1.17% | 7.66% | 2.41% |
Gross Profit
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Automation Enabling Technologies Gross Profit | 240.72M | 234.98M | 234.80M | |||||||||||
Automation Enabling Technologies Gross Profit Growth | 2.45% | 0.07% | -4.17% | |||||||||||
Medical Solutions Gross Profit (Post-Q3 2024 Reporting) | 193.14M | 189.96M | 170.79M | |||||||||||
Medical Solutions Gross Profit (Post-Q3 2024 Reporting) Growth | 1.68% | 11.22% | 22.84% | |||||||||||
Corporate and Shared Services Gross Profit | -3.62M | -3.39M | -5.69M | |||||||||||
Gross Profit (Total) | 430.25M | 421.55M | 399.90M | |||||||||||
Gross Profit (Total) Growth | 2.06% | 5.41% | 5.66% |
Gross Profit 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Precision Medicine and Manufacturing Gross Profit | - | - | 139.06M | |||||||||||
Precision Medicine and Manufacturing Gross Profit Growth | - | - | 7.65% | |||||||||||
Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) | - | - | 135.64M | |||||||||||
Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) Growth | - | - | 24.77% | |||||||||||
Robotics and Automation Gross Profit | - | - | 130.89M | |||||||||||
Robotics and Automation Gross Profit Growth | - | - | -10.45% | |||||||||||
Corporate and Shared Services Gross Profit | -3.62M | -3.39M | -5.69M | |||||||||||
Gross Profit (Total) | 430.25M | 421.55M | 399.90M | |||||||||||
Gross Profit (Total) Growth | 2.06% | 5.41% | 5.66% |
EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Automation Enabling Technologies Operating Income | 116.60M | 106.40M | 96.28M | |||||||||||
Automation Enabling Technologies Operating Income Growth | 9.59% | 10.51% | -8.67% | |||||||||||
Medical Solutions Operating Income (Post-Q3 2024 Reporting) | 43.61M | 57.53M | 63.26M | |||||||||||
Medical Solutions Operating Income (Post-Q3 2024 Reporting) Growth | -24.20% | -9.05% | 34.96% | |||||||||||
Corporate and Shared Services Operating Income | -64.33M | -53.35M | -49.04M | |||||||||||
Operating Income (Other) | 1,000.00 | - | - | |||||||||||
Operating Income (Total) | 95.89M | 110.58M | 110.50M | |||||||||||
Operating Income (Total) Growth | -13.29% | 0.08% | 7.20% |
EBIT 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Precision Medicine and Manufacturing Operating Income | - | - | 69.28M | |||||||||||
Precision Medicine and Manufacturing Operating Income Growth | - | - | 8.66% | |||||||||||
Medical Solutions Operating Income (Pre-Q4 2024 Reporting) | - | - | 41.88M | |||||||||||
Medical Solutions Operating Income (Pre-Q4 2024 Reporting) Growth | - | - | 48.29% | |||||||||||
Robotics and Automation Operating Income | - | - | 48.37M | |||||||||||
Robotics and Automation Operating Income Growth | - | - | -19.77% | |||||||||||
Corporate and Shared Services Operating Income | -64.33M | -53.35M | -49.04M | |||||||||||
Operating Income (Total) | 95.89M | 110.58M | 110.50M | |||||||||||
Operating Income (Total) Growth | -13.29% | 0.08% | 7.20% |
Updated Sep 26, 2025. Data Source: Fiscal.ai.